May 2 |
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
|
May 2 |
Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 2 |
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
|
May 2 |
Regeneron falls after Q1 miss; announces $3B share buybacks
|
May 2 |
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
|
May 2 |
Regeneron Earnings Miss; Biotech Giant's Stock Falls
|
May 2 |
Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook
|
May 2 |
Regeneron Reports First Quarter 2024 Financial and Operating Results
|
May 1 |
Regeneron Pharmaceuticals Q1 2024 Earnings Preview
|
May 1 |
Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
|